NRSN – neurosense therapeutics ltd. (US:NASDAQ)
Stock Stats
News
NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug [Yahoo! Finance]
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement
Form 6-K NeuroSense Therapeutics For: Mar 27
Form 6-K NeuroSense Therapeutics For: Mar 19
Form 424B5 NeuroSense Therapeutics
Form 6-K NeuroSense Therapeutics For: Feb 19
Form 424B3 NeuroSense Therapeutics
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.